Cargando…
Potential of mRNA vaccines to become versatile cancer vaccines
For centuries, therapeutic cancer vaccines have been developed and tried clinically. Way back in the late 19(th )century, the Father of Immunotherapy, William Coley had discovered that bacterial toxins were effective for inoperable sarcomas. In the 1970s, the Bacillus Calmette-Guérin (BCG) vaccine w...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476609/ https://www.ncbi.nlm.nih.gov/pubmed/36160466 http://dx.doi.org/10.5306/wjco.v13.i8.663 |